I don’t know, on one hand it seems like a no-brainer, I’m on Mounjaro myself(and it doesn’t really work all that well for me, but that’s another story) and GLP1 agonists in general are a true miracle drug. HOWEVER! On the other hand it seems disingenuous to only incentivise the most expensive drug in the category - my pharmacist once grumbled that ordering my Mounjaro was very costly to them. I’d rather see the cheaper (and European!) options prioritised as it might be less of a strain on the already overstretched NHS.
I don’t know, on one hand it seems like a no-brainer, I’m on Mounjaro myself(and it doesn’t really work all that well for me, but that’s another story) and GLP1 agonists in general are a true miracle drug. HOWEVER! On the other hand it seems disingenuous to only incentivise the most expensive drug in the category - my pharmacist once grumbled that ordering my Mounjaro was very costly to them. I’d rather see the cheaper (and European!) options prioritised as it might be less of a strain on the already overstretched NHS.